Table 4.
Observed incidence SSI, % [95% CI] | Expected incidence SSI, % [95% CI] | RAER, [95% CI] | p Value | |
---|---|---|---|---|
Skin preparation agent | ||||
CHG | 4.4 [3.1–6.0] | 4.9 [4.3–5.5] | 0.90 [0.63–1.22] | 0.48 |
CHG+IPA | 5.5 [4.5–6.7] | 5.3 [4.8–5.8] | 1.04 [0.85–1.26] | 0.67 |
PVI | 5.2 [3.4–7.7] | 5.0 [4.0–6.0] | 1.04 [0.68–1.54] | 0.85 |
IPC+IPA | 4.9 [2.7–8.1] | 4.9 [3.8–6.0] | 1.00 [0.55–1.65] | 0.99 |
Sub group IPA vs non-IPA | ||||
Non-IPA | 4.7 [3.6–6.0] | 5.0 [4.5–5.5] | 0.94 [0.72–1.19] | 0.65 |
IPA | 5.4 [4.5–6.5] | 5.2 [4.8–5.7] | 1.04 [0.87–1.25] | 0.69 |
CHG, chlorhexidine; CHG+IPA, chlorhexidine in isopropyl alcohol; PVI, povidone-iodine; IPC+IPA, povacrylx-iodine in isopropyl alcohol; IPA, isopropyl alcohol; RAER, risk adjusted event rates; SSI, surgical site infection.